COMMUNIQUÉS West-GlobeNewswire

MMI to Present on Company Momentum and Innovation at 44th Annual J.P. Morgan Healthcare Conference
06/01/2026
JACKSONVILLE, Fla., Jan. 06, 2026 (GLOBE NEWSWIRE) -- MMI (Medical Microinstruments, Inc.), a robotics company dedicated to expanding treatment options and improving outcomes for patients with complex conditions, today [...]
J-Star Announces Strategic Plan to Exit China and Accelerate Expansion in the United States
06/01/2026
TAICHUNG CITY, Taiwan, Jan. 06, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions serving diverse [...]
Clever Care Health Plan and CareMore Health Launch New Partnership to Expand Access to Care in Southern California
06/01/2026
New partnership adds over 350 primary care providers in three Southern California counties HUNTINGTON BEACH, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Clever Care Health Plan (“Clever Care”), a culturally sensitive and [...]
Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha DaRT® Study
06/01/2026
- Final results from first pancreatic cancer study in Montreal demonstrate 81% disease control rate, or 87% excluding the first two patients - - Immune markers demonstrate immune system preservation not typical of [...]
YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development
06/01/2026
Taipei, Taiwan, Jan. 06, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic [...]
Mapi Pharma is Seeking New Partnerships for Long-Acting Depot Drugs of Peptides for Self Administration
06/01/2026
Management to Participate in the 44th Annual J.P. Morgan Healthcare Conference NESS ZIONA, Israel, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development [...]
Day One Completes Acquisition of Mersana Therapeutics
06/01/2026
Acquisition expands Day One’s pipeline with clinical-stage antibody drug conjugate (ADC) emiltatug ledadotin (Emi-Le) targeting rare cancer adenoid cystic carcinoma (ACC) BRISBANE, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE [...]
Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative
06/01/2026
PHOENIX, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company advancing regenerative medicine and AI- [...]
Olympia Pharmaceuticals Launches Rebranded Website, Ushering in a New Era of Seamless Navigation and Advanced Features
06/01/2026
The updated site optimizes user interaction and strengthens Olympia's commitment to modern pharmaceutical solutions ORLANDO, Fla., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals , the nation’s leading 503A [...]
Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference
06/01/2026
REDWOOD CITY, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (NASDAQ: CHRS) today announced that senior management will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January [...]
QHSLab (OTCQB:USAQ) Issues Unaudited Financial and Operational Update Ahead of January 2026 Investor Session
06/01/2026
Unaudited update reflects revenue growth, positive operating income, removal of convertible debt, and improved cash flow profile entering 2026. Company reports $1.99 million in revenue for the nine months ended [...]
Medtech Incubator Partners with Leap Distributors to Support U.S. Market Expansion Efforts
06/01/2026
SCOTTSDALE, Arizona and DALLAS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Medtech Incubator announced today that it has partnered with Leap Distributors to support market adoption and expansion activities for emerging medical [...]
SoldierStrong Announces Annual SoldierScholar Recipients For 2025
06/01/2026
STAMFORD, Conn, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Delivering on its commitment to assist military veterans in taking a significant academic step forward in life after service, the national nonprofit SoldierStrong today [...]
Dewpoint Therapeutics Launches Initiative to Build Viral Condensate Phenomics Atlas for HPV
06/01/2026
Dewpoint to create a large-scale condensate phenomics atlas to illuminate cellular drivers of HPV-associated diseases Funded by the Gates Foundation to advance global health by improving understanding of HPV infection [...]
LQpay Launches Agentic AI API, Delivering Human-Like Access Across 125+ EMR/PM Systems Through a Single REST API
06/01/2026
Bridging the gap between human-centric design and digital automation, LQpay delivers a unified gateway for secure, bi-directional data exchange across 125+ healthcare systems FORT LAUDERDALE, Fla., Jan. 06, 2026 (GLOBE [...]
Apogee Therapeutics Announces Positive Interim Results from Phase 1b Trial of Zumilokibart (APG777), its Potentially Best-in-Class Anti-IL-13 Antibody, in Patients with Mild-to-Moderate Asthma and Highlights 2026 Anticipated Milestones and Outlook
06/01/2026
Phase 1b interim results of zumilokibart (APG777) in asthma demonstrated rapid and durable suppression of FeNO (key biomarker of Type 2 inflammation) through 16 weeks for all patients - Suppression of FeNO through 32 [...]
Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data
06/01/2026
Northwestern and Scripps Health join two previously announced sites in achieving this critical patient enrollment milestone Seven leading U.S. spine centers have now completed the regulatory and operational requirements [...]
Biosplice Announces the Submission of its New Drug Application (NDA) to the FDA for Lorecivivint (LOR) to Treat Knee Osteoarthritis
06/01/2026
LOR is the first drug candidate with disease-modifying potential for osteoarthritis submitted for approval, demonstrating statistically and clinically significant improvements in pain, function and medial joint space [...]
Johnson & Johnson submits application to the European Medicines Agency for TECVAYLI®▼ (teclistamab) in combination with DARZALEX® (daratumumab) subcutaneous formulation for patients with relapsed/refractory multiple myeloma
06/01/2026
Novel immunotherapy combination regimen brings together two complementary therapies to improve outcomes for people living with multiple myeloma as early as second line 1 The application is supported by data from the [...]

Pages